(Q59616733)
Statements
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer (English)
Peter Dubsky
Margaretha Rudas
Andrea Rottenfusser
Christoph C Zielinski
Guenther G Steger
Rupert Bartsch
Zsuzsanna Bago-Horvath
Catharina DeVries
27 March 2012